Dr. Joshua S. Weir

Internal Medicine
Pro Physicians Clinic PA
2077 N Webb Rd, 
Wichita, KS 
Accepting New Patients
Pro Physicians Clinic PA
2077 N Webb Rd, 
Wichita, KS 

Overview

Joshua Weir is a primary care provider, practicing in Internal Medicine in Wichita, Kansas.

His clinical expertise encompasses Breast Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 6 clinical trials. Dr. Weir is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Radiology in KS

Hospital Affiliations

Wesley Medical Center
Nmc Health

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Pro Physicians Clinic PA
2077 N Webb Rd, Wichita, KS 67206

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse With Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Enrollment Status: Terminated
Publish Date: May 20, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Memantine
Study Phase: Phase 3
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Use of Response-Adapted Hypofractionated Radiation Therapy to Potentiate the Systemic Immune Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: April 01, 2025
Intervention Type: Radiation, Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials

9 Total Publications

Photobiomodulation During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
Photobiomodulation During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
Journal: Advances in radiation oncology
Published: September 12, 2022
Similar Doctors
Expertise in
64
conditions
Dr. Jeremiah R. Kempke
Internal Medicine
Expertise in
64
conditions
Dr. Jeremiah R. Kempke
Internal Medicine

Hutchinson Clinic P.A. Inc.

8110 E 32nd St N Ste 180, 
Wichita, KS 
 (3.7 miles away)
620-669-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremiah Kempke is a primary care provider, practicing in Internal Medicine in Wichita, Kansas. Dr. Kempke is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Thyroid Storm, Hyperthyroidism, Type 2 Diabetes (T2D), and Type 1 Diabetes (T1D). Dr. Kempke is currently accepting new patients.

Expertise in
56
conditions
Dr. James A. Ruhlmann
Internal Medicine
Expertise in
56
conditions
Dr. James A. Ruhlmann
Internal Medicine
Before you request

Hutchinson Clinic P.A. Inc.

8110 E 32nd St N Ste 180, 
Wichita, KS 
 (3.7 miles away)
620-669-2500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Ruhlmann is a primary care provider, practicing in Internal Medicine in Wichita, Kansas. Dr. Ruhlmann is highly rated in 56 conditions, according to our data. His clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Sitosterolemia, and Hip Replacement. Dr. Ruhlmann is currently accepting new patients.

Expertise in
22
conditions
Dr. Mitchell A. Morgan
Internal Medicine
Expertise in
22
conditions
Dr. Mitchell A. Morgan
Internal Medicine

Kansas Spine & Specialty Hospital

3333 N Webb Rd, 
Wichita, KS 
 (1.5 miles away)
316-462-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mitchell Morgan is a primary care provider, practicing in Internal Medicine in Wichita, Kansas. Dr. Morgan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Gastroesophageal Reflux Disease (GERD). Dr. Morgan is currently accepting new patients.

Frequently Asked Questions about Dr. Joshua S. Weir

How do I make an appointment with Dr. Joshua S. Weir?

You can book an appointment with Dr. Joshua S. Weir by calling their office at 316-636-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joshua S. Weir a top-rated expert for Pancreaticoduodenectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joshua S. Weir is classified as an Experienced expert for Pancreaticoduodenectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joshua S. Weir specialize in?

While Dr. Joshua S. Weir is a Internal Medicine, they have specific expertise in Pancreaticoduodenectomy, Breast Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Joshua S. Weir participate in research or clinical trials?

Yes. Dr. Joshua S. Weir has published 9 articles and abstracts on conditions like Pancreaticoduodenectomy. You can view a list of Dr. Joshua S. Weir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joshua S. Weir accept my insurance?

Dr. Joshua S. Weir accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 316-636-6100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Weir's expertise for a condition
ConditionClose
        View All 20 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile